Recently, anti-tenascin-C single domain nanobodies have been developed that may also prove useful in a variety of imaging or compound-delivery applications [51], and other emerging techniques use radiolabeled or fluorescence-labelled tenascin-C aptamers for tumour detection [52, 53]. The gene discussed is TNC; the disease is neoplasm.